ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS
DATE OF LAUNCH

27 FEBRUARY 2007

CATEGORY

EQUITY

TYPE

LARGE & MIDCAP

AUM*

Rs.5,292 Crore

BENCHMARK

NIFTY LARGE MIDCAP 250

TOTAL RETURN INDEX

WHAT IT COSTS
NAV**

GROWTH OPTION

Rs.55.34

IDCW

Rs.23.32

MINIMUM INVESTMENT
Rs.100

MINIMUM SIP AMOUNT

Rs.100

EXPENSE RATIO*** (%)

1.89

EXIT LOAD

For units in excess of 25% of the investment,1% will be charged for redemption within 365 days

*AS ON 30 NOVEMBER 2022
**AS ON 5 JANUARY 2023
***AS ON 30 NOVEMBER 2022

FUND MANAGER

RAVI GOPALAKRISHNAN

TENURE: 11 MONTHS

Recent portfolio changes
New Entrants: The Indian Hotels Company, Triveni Turbine, Indusind Bank, Voltas.

Complete Exits: Gland Pharma, MRF, Samvardhana Motherson International.

Increasing allocation: Cholamandalam Investment & Finance, Oberoi Realty, United Breweries (Oct), FSN E-Commerce Ventures, TCI Express, The Indian Hotels Company, United Breweries (Nov).

Should you buy?

Earlier run as a multi cap offering Sundaram Equity Multiplier, this fund was designated a large and mid cap fund in 2018. The fund positioning itself has not budged, retaining a large cap tilt with up to 60% of corpus in it and the rest in mid caps. The portfolio is fairly diversified, but retains large positions in bigger companies and limits size of individual bets in mid cap space. The preference is for businesses with long growth runway. After two years of strong showing, the fund witnessed a blip in 2022, when market preferences shifted towards value stocks. A new yet experienced fund manager at the helm may need time to steer fund towards consistent outperformance.

(Source: Value Research)